Chemical Component Summary

Namepiperazine
Identifierspiperazine
FormulaC4 H10 N2
Molecular Weight86.14
TypeNON-POLYMER
Isomeric SMILESC1CNCCN1
InChIInChI=1S/C4H10N2/c1-2-6-4-3-5-1/h5-6H,1-4H2
InChIKeyGLUUGHFHXGJENI-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count16
Chiral Atom Count0
Bond Count16
Aromatic Bond Count0

Drug Info: DrugBank

DrugBank IDDB00592 
NamePiperazine
Groups
  • approved
  • vet_approved
DescriptionPiperazine is an organic compound that consists of a six-membered ring containing two opposing nitrogen atoms. First used as a solvent for uric acid, the use of piperazine as an anthelmintic agent was first introduced in 1953. Upon entry into the systemic circulation, the drug is partly oxidized and partly eliminated as an unchanged compound. Outside the body, piperazine has a remarkable power to dissolve uric acid and producing a soluble urate, but in clinical experience it has not proved equally successful. Piperazine was first introduced as an anthelmintic in 1953. Piperazine compounds mediate their anthelmintic action by generally paralyzing parasites, allowing the host body to easily remove or expel the invading organism.
Synonyms
  • Piperazina
  • Piperazine sulfate
  • Piperazidine
  • Piperazine hydrochloride
  • Diethylenediamine
Brand Names
  • Entacyl Suspension-600mg/5ml
  • Entacyl Granules 2.0gm
  • Formule C34
  • Entacyl Susp 0.6gm/5ml
  • Entacyl Granules
IndicationUsed as alternative treatment for ascariasis caused by <i>Ascaris lumbricoides</i> (roundworm) and enterobiasis (oxyuriasis) caused by <i>Enterobius vermicularis</i> (pinworm). It is also used to treat partial intestinal obstruction by the common roundworm, a condition primarily occurring in children.
Categories
  • Anthelmintics
  • Anti-Infective Agents
  • Antinematodal Agents
  • Antiparasitic Agents
  • Antiparasitic Products, Insecticides and Repellents
ATC-CodeP02CB01
CAS number110-85-0

Drug Targets

NameTarget SequencePharmacological ActionActions
Gamma-aminobutyric acid receptor subunit beta-3MWGLAGGRLFGIFSAPVLVAVVCCAQSVNDPGNMSFVKETVDKLLKGYDI...unknownagonist
Cytochrome P450 2D6MGLEALVPLAVIVAIFLLLVDLMHRRQRWAARYPPGPLPLPGLGNLLHVD...unknownsubstrate
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
CCDC/CSDAKUFOB
PubChem4837
ChEBICHEBI:28568
ChEMBLCHEMBL1412